Screener
Travere Therapeutics, Inc. TVTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Total current assets | 392,681 | 437,565 |
| Long-term inventory | 30,698 | 30,280 |
| Property and equipment, net | 3,627 | 4,022 |
| Operating lease right of use assets | 9,668 | 10,576 |
| Intangible assets, net | 110,038 | 113,868 |
| Other assets | 8,476 | 8,880 |
| Total assets | $555,188 | $605,191 |
| Liabilities and Stockholders' Equity |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s operating lease ROU assets?
- Travere Therapeutics, Inc. (TVTX) reported operating lease ROU assets of $9.67M in Q1 2026.
- How has Travere Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Travere Therapeutics, Inc.'s operating lease ROU assets decreased by 26.7% year-over-year, from $13.2M to $9.67M.
- What is the long-term trend for Travere Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s operating lease ROU assets has grown at a -16.3% compound annual growth rate (CAGR), from $25.68M to $10.58M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Travere Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude